- Home
- SNTI vs ELSE Comparison
SNTI vs ELSE Comparison
Compare SNTI & ELSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- ELSE
- Stock Information
- Founded
- SNTI 2016
- ELSE 1968
- Country
- SNTI United States
- ELSE United States
- Employees
- SNTI N/A
- ELSE N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- ELSE Industrial Machinery/Components
- Sector
- SNTI Health Care
- ELSE Industrials
- Exchange
- SNTI Nasdaq
- ELSE Nasdaq
- Market Cap
- SNTI 14.1M
- ELSE 13.2M
- IPO Year
- SNTI N/A
- ELSE N/A
- Fundamental
- Price
- SNTI $2.27
- ELSE $3.90
- Analyst Decision
- SNTI
- ELSE
- Analyst Count
- SNTI 0
- ELSE 0
- Target Price
- SNTI N/A
- ELSE N/A
- AVG Volume (30 Days)
- SNTI 19.6K
- ELSE 2.2K
- Earning Date
- SNTI 11-11-2024
- ELSE 11-12-2024
- Dividend Yield
- SNTI N/A
- ELSE N/A
- EPS Growth
- SNTI N/A
- ELSE N/A
- EPS
- SNTI N/A
- ELSE 0.06
- Revenue
- SNTI $338,000.00
- ELSE $8,834,000.00
- Revenue This Year
- SNTI $254.47
- ELSE N/A
- Revenue Next Year
- SNTI $169.66
- ELSE N/A
- P/E Ratio
- SNTI N/A
- ELSE $63.66
- Revenue Growth
- SNTI N/A
- ELSE 3.78
- 52 Week Low
- SNTI $1.52
- ELSE $3.65
- 52 Week High
- SNTI $8.48
- ELSE $4.40
- Technical
- Relative Strength Index (RSI)
- SNTI 36.32
- ELSE 46.18
- Support Level
- SNTI $2.05
- ELSE $3.91
- Resistance Level
- SNTI $2.46
- ELSE $4.05
- Average True Range (ATR)
- SNTI 0.22
- ELSE 0.03
- MACD
- SNTI -0.08
- ELSE -0.01
- Stochastic Oscillator
- SNTI 12.90
- ELSE 0.00
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About ELSE Electro-Sensors Inc.
Electro-Sensors Inc is engaged in manufacturing and selling a variety of monitoring systems that measure actual machine production and operation rates, as well as systems that regulate the speed of related machines in production processes. Its speed monitoring systems compare revolutions per minute or speed against acceptable rates as determined by a customer. It also includes a line of products that measure production counts or rates, such as parts, gallons, or board feet, alarm systems, tachometers, and other devices that translate impulses from the sensors into alarm signals, computer inputs, or digital displays that are usable by the customer.